• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Introduction to a review series on myelodysplastic syndromes.

作者信息

Löwenberg Bob

机构信息

Editor-in-Chief, Blood.

出版信息

Blood. 2019 Mar 7;133(10):1001. doi: 10.1182/blood-2018-12-886549. Epub 2019 Jan 22.

DOI:10.1182/blood-2018-12-886549
PMID:30670447
Abstract
摘要

相似文献

1
Introduction to a review series on myelodysplastic syndromes.
Blood. 2019 Mar 7;133(10):1001. doi: 10.1182/blood-2018-12-886549. Epub 2019 Jan 22.
2
The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment.骨髓增生异常综合征的不断演变的临床情况：需要进行全面和最新的初始诊断评估。
Eur J Intern Med. 2010 Dec;21(6):490-5. doi: 10.1016/j.ejim.2010.09.003. Epub 2010 Oct 12.
3
MDS researchers seek treatments but find few.
J Natl Cancer Inst. 2007 Jul 4;99(13):996-7. doi: 10.1093/jnci/djm055. Epub 2007 Jun 27.
4
[Recommendations for the cytogenetic management of myelodysplastic syndrome by the French Group fo Cytogenetic Hematology].法国细胞遗传学血液学小组关于骨髓增生异常综合征细胞遗传学管理的建议
Pathol Biol (Paris). 2004 Jun;52(5):245-7. doi: 10.1016/j.patbio.2004.04.005.
5
Highlights in Myelodysplastic Syndromes From the 60th American Society of Hematology Annual Meeting.
Clin Adv Hematol Oncol. 2019 Feb;17 Suppl 5(2):1-19.
6
Research in morphology and flow cytometry is at the heart of hematology.形态学和流式细胞术研究是血液学的核心。
Haematologica. 2017 Mar;102(3):421-422. doi: 10.3324/haematol.2016.163147.
7
Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?审视骨髓增生异常综合征/骨髓增殖性肿瘤的研究概况：重叠综合征之间的重叠情况？
Hematology Am Soc Hematol Educ Program. 2015;2015:349-54. doi: 10.1182/asheducation-2015.1.349.
8
Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress.
Clin Adv Hematol Oncol. 2020 Sep;18 Suppl 14(9):1-24.
9
Highlights in myelodysplastic syndromes from the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: commentary.2020年美国临床肿瘤学会年会及第25届欧洲血液学协会大会中骨髓增生异常综合征的亮点：评论
Clin Adv Hematol Oncol. 2020 Sep;18 Suppl 14(9):20-23.
10
What's new in haematology?
Med J Aust. 1994 Jan 3;160(1):38-40.

引用本文的文献

1
Past, present and future in low-risk myelodysplastic syndrome.低风险骨髓增生异常综合征的过去、现在与未来
Front Med (Lausanne). 2022 Jul 15;9:967900. doi: 10.3389/fmed.2022.967900. eCollection 2022.
2
Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.一种新型骨髓增生异常综合征衍生细胞系的临床前表征与开发
Br J Haematol. 2021 Apr;193(2):415-419. doi: 10.1111/bjh.17372. Epub 2021 Mar 9.
3
Clinical Response to Traditional Chinese Herbs Containing Realgar (AsS) is Related to DNA Methylation Patterns in Bone Marrow DNA from Patients with Myelodysplastic Syndrome with Multilineage Dysplasia.
含雄黄（AsS）的中药对多系发育异常的骨髓增生异常综合征患者骨髓DNA甲基化模式的临床反应。
Cancer Manag Res. 2021 Jan 7;13:55-63. doi: 10.2147/CMAR.S280886. eCollection 2021.